Acute Ischemic Stroke Management
For adults presenting with acute ischemic stroke symptoms, immediately stabilize the airway and circulation, obtain non-contrast CT within 25 minutes to exclude hemorrhage, and administer IV alteplase (0.9 mg/kg, max 90 mg) within 3 hours (or up to 4.5 hours in select patients) if no contraindications exist, followed by admission to a specialized stroke unit with continuous monitoring. 1, 2
Immediate Assessment and Stabilization (First 10 Minutes)
ABCs and Vital Signs
- Ensure airway patency, adequate ventilation, and circulatory support immediately upon arrival 1, 2
- Administer supplemental oxygen only if oxygen saturation <94% (not routinely for all patients) 1
- Establish IV access and obtain blood samples for complete blood count, coagulation studies (PT/INR, aPTT), comprehensive metabolic panel, blood glucose, and cardiac biomarkers 1, 2
- Perform 12-lead ECG to identify atrial fibrillation or acute myocardial infarction as potential stroke etiology 1, 2
Neurological Assessment
- Determine the exact time the patient was last known to be at baseline (not when symptoms were discovered)—this is the "time zero" for treatment decisions 1, 2
- Perform National Institutes of Health Stroke Scale (NIHSS) assessment to quantify stroke severity 1, 2
- Identify and immediately treat hypoglycemia if blood glucose <50 mg/dL (2.7 mmol/L), as this is a stroke mimic and exclusion criterion for thrombolysis 1
Emergency Neuroimaging (Within 25 Minutes)
Non-Contrast CT Brain
- Complete CT scan within 25 minutes of ED arrival and interpret within 45 minutes 1, 2
- The primary purpose is to exclude intracranial hemorrhage—if hemorrhage is present, the patient is absolutely not a candidate for thrombolysis 1
- Early ischemic changes (hypodensity affecting >1/3 of cerebral hemisphere) on baseline CT do not preclude rtPA treatment within 3 hours 1
Advanced Imaging Considerations
- CT angiography, CT perfusion, or multimodal MRI may be obtained but must not delay IV rtPA administration in eligible patients presenting within the treatment window 1, 2
- Vascular imaging is necessary before intra-arterial thrombolysis or mechanical thrombectomy but should not delay IV rtPA 1
Blood Pressure Management
For Thrombolysis Candidates
- Blood pressure must be <185/110 mmHg before administering rtPA 1
- If BP is 185-230 systolic or 105-120 diastolic, treat with: 1
- Labetalol 10-20 mg IV over 1-2 minutes (may repeat once), OR
- Nicardipine IV 5 mg/hr, titrate by 2.5 mg/hr every 5-15 minutes to max 15 mg/hr
- If BP cannot be lowered to <185/110 mmHg, do not administer rtPA 1
During and After rtPA Administration
- Monitor BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours 1
- Maintain BP <180/105 mmHg for at least 24 hours post-thrombolysis 3
- If BP rises to 180-230 systolic or 105-120 diastolic during/after rtPA, use labetalol or nicardipine as above 1
For Non-Thrombolysis Candidates
- Only lower BP if systolic >220 mmHg or diastolic >120 mmHg 1, 3
- Reduce BP by 15-25% within the first 24 hours if treatment is indicated 1
- Permissive hypertension is the standard approach—aggressive BP lowering reduces cerebral perfusion to the ischemic penumbra 3
Intravenous Thrombolysis with Alteplase
Inclusion Criteria for 0-3 Hour Window 1
- Diagnosis of ischemic stroke causing measurable neurologic deficit
- Symptom onset <3 hours before treatment initiation
- Age ≥18 years
Inclusion Criteria for 3-4.5 Hour Window 1
- Same as above, but symptom onset 3-4.5 hours before treatment
- Additional exclusions for this extended window:
- Age >80 years
- NIHSS >25 (severe stroke)
- Taking oral anticoagulants regardless of INR
- History of both diabetes AND prior ischemic stroke
Absolute Exclusion Criteria 1
- Head trauma or prior stroke in previous 3 months
- Symptoms suggesting subarachnoid hemorrhage
- History of intracranial hemorrhage
- Intracranial or spinal surgery within 3 months
- Arterial puncture at non-compressible site in previous 7 days
- Systolic BP >185 mmHg or diastolic >110 mmHg (that cannot be controlled)
- Evidence of active bleeding
- Platelet count <100,000/mm³
- INR >1.7 or PT >15 seconds
- Heparin within 48 hours with elevated aPTT
- Blood glucose <50 mg/dL
- CT showing multilobar infarction (hypodensity >1/3 cerebral hemisphere)
Dosing and Administration
- Alteplase 0.9 mg/kg (maximum 90 mg total dose) 4
- Give 10% as IV bolus over 1 minute, then remaining 90% as continuous infusion over 60 minutes 4
Special Consideration: Rapidly Improving Symptoms
- If neurologic signs are spontaneously clearing and function is rapidly improving to near baseline, thrombolysis may not be required 1
- This requires clinical judgment—the patient should be approaching normal function, not just showing mild improvement
Mechanical Thrombectomy
Patient Selection
- Patients with large vessel occlusion (internal carotid artery, M1 or proximal M2 middle cerebral artery segments) should receive mechanical thrombectomy at experienced centers 4, 5
- Thrombectomy can be performed up to 24 hours from symptom onset in carefully selected patients with favorable imaging profiles 5
- Do not delay IV rtPA to arrange thrombectomy—give rtPA first if within the time window, then proceed to thrombectomy 4
Institutional Requirements
- Facilities must have immediate access to cerebral angiography and credentialed interventionalists 4
- Hospitals performing <5 thrombectomies per year have increased mortality risk 4
Admission and Monitoring
Stroke Unit Care
- All patients must be admitted to a specialized stroke unit—this intervention provides mortality and morbidity benefits comparable to thrombolysis itself 3
- Continuous cardiac monitoring for at least 24 hours to detect atrial fibrillation and life-threatening arrhythmias 1
- Neurological assessments using NIHSS every 15 minutes during thrombolysis, then hourly for 6 hours, then every 2 hours for 18 hours 3
NPO Status and Aspiration Prevention
- Keep patient NPO until formal swallowing assessment is completed 3
- Perform bedside swallowing screen (water swallow test) within 24 hours before allowing any oral intake 3
- Patients with brainstem infarctions, depressed consciousness, dysphonia, or cranial nerve palsies are at highest aspiration risk 3
- Aspiration pneumonia significantly worsens outcomes—this is a critical pitfall to avoid 3
Temperature Management
- Monitor temperature every 4 hours for first 48 hours 3
- Treat fever aggressively if temperature exceeds 37.5°C (99.5°F) with acetaminophen and cooling measures, as hyperthermia worsens neurological damage 3
Glucose Management
- Check fingerstick glucose every 6 hours for first 24 hours 3
- Maintain glucose 140-180 mg/dL; treat if >180 mg/dL with sliding scale insulin 3
Antiplatelet Therapy
Timing Based on Thrombolysis Status
- If rtPA was given: Delay aspirin for 24 hours and obtain repeat head CT to exclude hemorrhagic transformation before starting 3, 4
- If rtPA was NOT given: Start aspirin 160-325 mg within 24-48 hours of symptom onset 3, 4
Venous Thromboembolism Prophylaxis
- Apply intermittent pneumatic compression devices to both legs within 24 hours 3
- Consider subcutaneous heparin 5000 units every 8-12 hours or enoxaparin 40 mg daily after 24 hours if no hemorrhagic transformation on repeat imaging 3
- Do not use subcutaneous heparin in first 24 hours after thrombolysis due to bleeding risk 3
Early Mobilization and Rehabilitation
- Begin early mobilization within 24 hours if patient is stable 3
- Initial bed rest with head of bed flat or at 30 degrees (avoid extreme head elevation which may reduce cerebral perfusion) 3
- Physical therapy, occupational therapy, and speech therapy consultations within 24 hours 3
- Prolonged immobility beyond 24 hours increases complications including pneumonia, DVT, pulmonary embolism, and pressure sores 3
Repeat Imaging
- Obtain repeat non-contrast head CT at 24 hours (or sooner if neurological deterioration) to assess for hemorrhagic transformation, especially if thrombolysis was given 3
Critical Pitfalls to Avoid
- Do not delay thrombolysis to obtain advanced imaging (CT angiography, MRI perfusion) in patients presenting within 3-4.5 hours 1
- Do not aggressively lower blood pressure in acute stroke unless specific criteria are met—permissive hypertension maintains cerebral perfusion 3
- Do not give oral medications, food, or water before swallowing assessment—aspiration pneumonia is a leading cause of post-stroke death 3
- Do not withhold thrombolysis based solely on high NIHSS scores (severe symptoms)—even patients with NIHSS ≥25 may benefit within 4.5 hours 1
- Protocol violations during thrombolysis administration significantly increase symptomatic intracranial hemorrhage risk and mortality 4